# Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites

> **NCT03963947** · — · COMPLETED · sponsor: **Alfons Malet i Casajuana** · enrollment: 97 (actual)

## Conditions studied

- Rhinoconjunctivitis With or Without Allergic Asthma

## Interventions

- **BIOLOGICAL:** Beltavac® Polymerized with house dust mites

## Key facts

- **NCT ID:** NCT03963947
- **Lead sponsor:** Alfons Malet i Casajuana
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2023-05-24
- **Final completion:** 2023-05-24
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963947, "Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03963947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*